Jump to main content
Jump to site search

Issue 5, 2017
Previous Article Next Article

Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines

Author affiliations

Abstract

Cyclopeptides have been recently used successfully as carriers for the multivalent presentation of carbohydrate and peptide antigens in immunotherapy. Beside their synthetic versatility, these scaffolds are indeed interesting due to their stability against enzyme degradation and low immunogenicity. This mini-review highlights the recent advances in the utilization of cyclopeptides to prepare fully synthetic vaccines prototypes against cancers and pathogens.

Graphical abstract: Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines

Back to tab navigation

Publication details

The article was received on 25 Jan 2017, accepted on 03 Mar 2017 and first published on 09 Mar 2017


Article type: Minireview
DOI: 10.1039/C7BM00072C
Citation: Biomater. Sci., 2017,5, 953-965
  •   Request permissions

    Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines

    C. Pifferi, N. Berthet and O. Renaudet, Biomater. Sci., 2017, 5, 953
    DOI: 10.1039/C7BM00072C

Search articles by author

Spotlight

Advertisements